Liaoning He Eye Hospital Group Adjusts Evaluation Amid Mixed Financial Performance Indicators

Liaoning He Eye Hospital Group Co., Ltd., a small-cap player in the hospital industry, has recently undergone an evaluation adjustment that reflects its current market standing. The company has reported notable financial metrics for the quarter ending March 2026, showcasing a growth in net sales of 4.7%. This positive trend is complemented by a significant increase in net profit, which reached CNY 5.07 million, marking a remarkable growth of 142.78%. Additionally, the raw material costs have decreased by 8.18% year-over-year, contributing to improved operational efficiency, as evidenced by an inventory turnover ratio of 9.25 times. Despite these positive developments, the company faces challenges with management efficiency, indicated by a return on capital employed (ROCE) of 13.86%. Furthermore, the long-term growth trajectory has been modest, with net sales growing at an annual rate of 2.35% and operating profit declining by 59.75% over the past five years. The stock has also shown consistent underperformance against the benchmark, generating a return of -18.68% over the last year. In light of these factors, the evaluation of Liaoning He Eye Hospital Group Co., Ltd. has been revised, reflecting the complexities of its financial landscape. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.